
NTLA Stock Getting Ahead in Gene Editing Race By TipRanks
© Reuters. NTLA Stock Getting Ahead in Gene Editing Race It has been a colossal year for gene-editing giant Intellia Therapeutics (NASDAQ:). The biotech company has received significantly positive results from its recent clinical trials. […]